A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
Extensive-stage Small-cell Lung Cancer
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
- +10
Pushed back a key date by about 18 months
Since Nov 6, 2026 · was worth 10, fading over time
- +1.5
3 insiders sold shares within a month
Since May 28, 2026 · was worth 10, fading over time
Score over time
- Stage
- Phase 2
- Patients
- 50 (planned)
- Started
- Oct 12, 2026
- Main results expected
- Aug 4, 2029
- Fully finished
- Nov 4, 2029
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Investigator assessed PFS rate
Measured over: 6 months
Changes Tremor has spotted
Pushed back the final finish date by about 18 months: Apr 30, 2028 → Nov 4, 2029.
Spotted
Pushed back the main results date by about 18 months: Jan 31, 2028 → Aug 4, 2029.
Jazz Pharmaceuticals pushed back the date when the main results from its lung cancer study are expected, from 2028-01-31 to 2029-08-04, about 18 months later. The study is a mid-stage test (called Phase 2) that is still enrolling patients, meaning it is still signing up people to take part, with 50 planned. Investors watch a delay like this because it can sometimes signal that enrollment or the study itself is running slower than planned, but a date change can also come from routine scheduling, and the company hasn't said why it moved. On its own, this change doesn't prove that anything is wrong with the study.
AI-written from the facts above
Spotted
Show details (technical version)
Score inputs
- date_delayed: base 10, now 10, since 2026-11-06, fades (half-life)
- insider_selling_cluster: base 10, now 1.5, since 2026-05-28, fades (half-life)
Raw record changes
- 2026-11-06 15:29 UTC · date_delayed · completion_date
old: "2028-04-30"
new: "2029-11-04"
details: {"months":18.2} - 2026-11-06 15:29 UTC · date_delayed · primary_completion_date
old: "2028-01-31"
new: "2029-08-04"
details: {"months":18.1}
Trial ID NCT07459634 · record last updated 2026-11-06 · checked 2026-11-09 06:30 UTC